Skip to content
OpenCapital
Get started

10x Genomics, Inc. TXG Q4 2025 Annual earnings

Reported February 12, 2026 · After market close

Revenue$166.0MBeat by $6.4M
EPS-$0.13Beat by $0.06
Revenue estimate$159.7M
EPS estimate-$0.19

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$146.7M
EPS estimate-$0.23

Financials

Q4 2025

Income statement

See full
Revenue$166.0M+0.6%
Gross profit$113.0M+1.9%
Operating income-$19.5M+60.8%
Net income-$16.3M+66.9%
EPS (diluted)-$0.13+68.3%

Balance sheet

See full
Cash & equivalents$474.0M+37.8%
Total debt$84.4M+2.1%
Total equity$796.3M+12.1%
Total assets$1.0B+13.4%

Cash flow

See full
Operating cash flow$40.8M—
CapEx$1.8M-34.6%
Free cash flow$39.0M+512%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$2.06B+18.7%
Enterprise value$1.67B+13.4%
P/S3.2×+0.4×

Profitability

See full
Gross margin69.1%+1.2pp
Operating margin-9.5%-3.9pp
Net margin-6.8%-3.0pp
FCF margin20.2%—

Returns & leverage

See full
Return on equity-5.8%-2.5pp
Debt / equity0.1×0.0×
Current ratio4.5×-0.5×

Segments

By product

See full
Products and services revenue$165.7M—
Single Cell$90.8M—
Spatial$9.4M-30.2%
Services$8.5M+20.6%
License and royalty revenue$341.0K—

By geography

See full
Europe, Middle East and Africa$53.5M+7.3%
Asia-Pacific (excluding China)$15.4M+15.0%
Americas (excluding United States)$3.2M+9.6%

Versus estimates

Revenue

Q1 2026$150.8MBeat by $4.4M
Q4 2025$166.0MBeat by $6.4M
Q3 2025$149.0MBeat by $6.5MQ2 2025$172.9MBeat by $33.4MQ1 2025$154.9MBeat by $9.6MQ4 2024$165.0MIn line

Diluted EPS

Q1 2026-$0.10Beat by $0.19
Q4 2025-$0.13Beat by $0.06
Q3 2025-$0.22Miss by $0.15Q2 2025$0.28Beat by $0.63Q1 2025-$0.36Beat by $0.09Q4 2024-$0.40Miss by $0.11

Ask the moment 10x Genomics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did 10x Genomics, Inc. report Q4 2025 earnings?
10x Genomics, Inc. (TXG) reported Q4 2025 earnings on February 12, 2026 after market close.
What were 10x Genomics, Inc.'s Q4 2025 revenue and EPS?
10x Genomics, Inc. reported revenue of $166.0M and eps of $-0.13 for Q4 2025.
Did 10x Genomics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $159.7M by $6.4M. EPS beat the consensus estimate of $-0.19 by $0.06.
How did 10x Genomics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.6% from $165.0M a year earlier and eps grew 67.5% from $-0.40.
Where can I find 10x Genomics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-007673) and the 10-K periodic report (0001628280-26-007822) directly on SEC EDGAR. The filing index links above go to sec.gov.